JAK2 and B-cell chronic lymphocytic leukemia: In agreement with this hypothesis, JAK2 protein was decreased over time in OSU-CLL cells treated with ACY738 (Figures 4E, F), while acetylation of HSP90 at lysine 294 was increased (Figures 4G, H).